RNF169
Basic information
Region (hg38): 11:74748849-74842413
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (99 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RNF169 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001098638.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 94 | 99 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 94 | 5 | 0 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RNF169 | protein_coding | protein_coding | ENST00000299563 | 6 | 93546 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0395 | 0.960 | 124768 | 0 | 35 | 124803 | 0.000140 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.358 | 303 | 321 | 0.944 | 0.0000183 | 4499 |
Missense in Polyphen | 104 | 126.73 | 0.82067 | 1659 | ||
Synonymous | -1.89 | 149 | 122 | 1.22 | 0.00000612 | 1508 |
Loss of Function | 3.20 | 7 | 23.9 | 0.293 | 0.00000150 | 321 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000463 | 0.000463 |
Ashkenazi Jewish | 0.0000993 | 0.0000993 |
East Asian | 0.000112 | 0.000111 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000106 | 0.000106 |
Middle Eastern | 0.000112 | 0.000111 |
South Asian | 0.0000981 | 0.0000980 |
Other | 0.000165 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Probable E3 ubiquitin-protein ligase that acts as a negative regulator of double-strand breaks (DSBs) repair following DNA damage. Recruited to DSB repair sites by recognizing and binding ubiquitin catalyzed by RNF168 and competes with TP53BP1 and BRCA1 for association with RNF168-modified chromatin, thereby acting as a negative regulator of DSBs repair. E3 ubiquitin- protein ligase activity is not required for regulation of DSBs repair. {ECO:0000269|PubMed:22492721, ECO:0000269|PubMed:22733822, ECO:0000269|PubMed:22742833}.;
Intolerance Scores
- loftool
- 0.577
- rvis_EVS
- -0.56
- rvis_percentile_EVS
- 19.73
Haploinsufficiency Scores
- pHI
- 0.421
- hipred
- N
- hipred_score
- 0.372
- ghis
- 0.502
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.134
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rnf169
- Phenotype
- homeostasis/metabolism phenotype; immune system phenotype; skeleton phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- cellular response to DNA damage stimulus;protein ubiquitination;negative regulation of double-strand break repair
- Cellular component
- nucleus;nucleoplasm;nuclear speck;site of double-strand break
- Molecular function
- transferase activity;nucleosome binding;metal ion binding;K63-linked polyubiquitin modification-dependent protein binding